Showing 1,801–1,850 of 20,598 genes

#	Gene	Name	Chr	Tags	PubMed	PubMed Papers
1801	AIRE	autoimmune regulator	21	Transcription FactorOMIM Disease Gene	225	225
1802	APOBEC3B	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	22	TrendingExperimental GO Evidence	225	225
1803	BNIP3	BCL2 interacting protein 3	10	TrendingExperimental GO Evidence	225	225
1804	CCND3	cyclin D3	6	Transcription FactorTrending	225	225
1805	CSF3	colony stimulating factor 3	17	Hub GeneTrending	225	225
1806	DHFR	dihydrofolate reductase	5	FDA Approved TargetOMIM Disease Gene	225	225
1807	HNRNPA0	heterogeneous nuclear ribonucleoprotein A0	5	TrendingExperimental GO Evidence	225	225
1808	MSTN	myostatin	2	Clinical TrialsOMIM Disease Gene	225	225
1809	NKX2-5	NK2 homeobox 5	5	Highly ConstrainedTranscription Factor	225	225
1810	NUP214	nucleoporin 214	9	Hub GeneOncogene	225	225
1811	RAB8A	RAB8A, member RAS oncogene family	19	Highly ConstrainedHub Gene	225	225
1812	RPL36	ribosomal protein L36	19	Hub GeneFDA Approved Target	225	225
1813	TTK	TTK protein kinase	6	Hub GeneKinase	225	225
1814	ARHGDIA	Rho GDP dissociation inhibitor alpha	17	OMIM Disease GeneExperimental GO Evidence	224	224
1815	DCD	dermcidin	12	ProteaseTrending	224	224
1816	E2F3	E2F transcription factor 3	6	Transcription FactorClinical Trials	224	224
1817	EIF2S3	eukaryotic translation initiation factor 2 subunit gamma	X	Highly ConstrainedHub Gene	224	224
1818	PCMT1	protein-L-isoaspartate (D-aspartate) O-methyltransferase	6	TrendingExperimental GO Evidence	224	224
1819	RBBP8	RB binding protein 8, endonuclease	18	DNA RepairHomologous Recombination	224	224
1820	RPL26	ribosomal protein L26	17	Highly ConstrainedHub Gene	224	224
1821	RPL35	ribosomal protein L35	9	Hub GeneFDA Approved Target	224	224
1822	SEC16A	SEC16 homolog A, endoplasmic reticulum export factor	9	TransporterExperimental GO Evidence	224	224
1823	SNRPE	small nuclear ribonucleoprotein polypeptide E	1	Hub GeneOMIM Disease Gene	224	224
1824	TFEB	transcription factor EB	6	Transcription FactorTrending	224	224
1825	TLR1	toll like receptor 1	4	ReceptorTrending	224	224
1826	TPR	translocated promoter region, nuclear basket protein	1	Highly ConstrainedHub Gene	224	224
1827	CIITA	class II major histocompatibility complex transactivator	16	KinaseTranscription Factor	223	223
1828	CLIC1	chloride intracellular channel 1	6	Ion ChannelTransporter	223	223
1829	FABP2	fatty acid binding protein 2	4	TransporterTrending	223	223
1830	HNRNPDL	heterogeneous nuclear ribonucleoprotein D like	4	Hub GeneTranscription Factor	223	223
1831	IRS4	insulin receptor substrate 4	X	OMIM Disease GeneExperimental GO Evidence	223	223
1832	NACA	nascent polypeptide associated complex subunit alpha	12	Hub GeneTranscription Factor	223	223
1833	RPL34	ribosomal protein L34	4	Hub GeneFDA Approved Target	223	223
1834	THY1	Thy-1 cell surface antigen	11	TrendingExperimental GO Evidence	223	223
1835	WDR77	WD repeat domain 77	1	TrendingExperimental GO Evidence	223	223
1836	AIMP1	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	4	OMIM Disease GeneTrending	222	222
1837	APAF1	apoptotic peptidase activating factor 1	12	Experimental GO EvidenceSwiss-Prot Reviewed	222	222
1838	CKAP5	cytoskeleton associated protein 5	11	Highly ConstrainedTrending	222	222
1839	FLOT2	flotillin 2	17	TrendingExperimental GO Evidence	222	222
1840	GAB1	GRB2 associated binding protein 1	4	OMIM Disease GeneTrending	222	222
1841	GSTA1	glutathione S-transferase alpha 1	6	Hub GeneTrending	222	222
1842	H2AZ1	H2A.Z variant histone 1	4	Hub GeneTrending	222	222
1843	KPNA3	karyopherin subunit alpha 3	13	Highly ConstrainedTransporter	222	222
1844	OXT	oxytocin/neurophysin I prepropeptide	20	TrendingExperimental GO Evidence	222	222
1845	PAK4	p21 (RAC1) activated kinase 4	19	KinaseEarly Pipeline	222	222
1846	PSMB2	proteasome 20S subunit beta 2	1	Hub GeneFDA Approved Target	222	222
1847	RTCB	RNA 2',3'-cyclic phosphate and 5'-OH ligase	22	TrendingExperimental GO Evidence	222	222
1848	SLC6A2	solute carrier family 6 member 2	16	TransporterFDA Approved Target	222	222
1849	TACR1	tachykinin receptor 1	2	ReceptorFDA Approved Target	222	222
1850	TFE3	transcription factor binding to IGHM enhancer 3	X	Highly ConstrainedOncogene	222	222